Drug development for Alzheimer’s disease has been a series of disappointments, with only faint glimmers of hope from pharmaceutical companies or academic labs. What causes the disease is still hotly debated, with the amyloid hypothesis losing believers after each new trial failure.
But before those drugs targeting amyloid plaques or tau tangles failed in human trials, they generally succeeded in preclinical studies — specifically, ones done with mice. Right now, about 160 mouse models for Alzheimer’s exist. But none is particularly good, experts say.
About the Author Reprints
Too bad the public is so misinformed that they have no idea that mouse trials rarely represent humans. This is an Advertorial written to stimulate funding for these failed scientific dead ends. there is no mouse model for any type of Dementia, yet selling it as if there is can be profitable. Dementia an be misdiagnosed for years by Physicians. Soon it will be a leading cause of death. The Medical Industry refuses to diagnose or even acknowledge these conditions until it is much to late.